Adaptive response induced by mitomycin C measuring the frequency of SCEs in human lymphocyte cultures. 1994

E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
Depto. de Morfologia, Escuela Nacional de Ciencias Biológicas, IPN, México, D.F.

The induction of an adaptive response was obtained using mitomycin C (MMC) as both stimulating and challenging agent. Human lymphocyte cultures of two female donors were treated with 5, 10 and 20 ng/ml of MMC as conditioning doses. For the challenging treatments two different protocols were used (200 ng/ml for 4 h, and 400 ng/ml for 1 h). The scoring of sister chromatid exchanges (SCE) in the first challenging combination showed the following inhibition related with the expected SCE damage: 49.2%, 51.4%, and 36.9% for one donor, and 42.0%, 38.6%, and 34.7% for the other (corresponding to the stimulating dosages 5, 10, and 20 ng/ml, respectively). The second challenging combination gave an inhibition of 53.8%, 40.5% and 30.2% in one donor and 43.2%, 45.9% and 30.3% in the other donor.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012854 Sister Chromatid Exchange An exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME. Chromatid Exchange, Sister,Chromatid Exchanges, Sister,Exchange, Sister Chromatid,Exchanges, Sister Chromatid,Sister Chromatid Exchanges
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
August 2013, Cytotechnology,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
February 1983, Mutation research,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
June 1988, Nihon eiseigaku zasshi. Japanese journal of hygiene,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
January 2005, Biochemical and biophysical research communications,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
April 1998, The Tohoku journal of experimental medicine,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
April 1980, Carcinogenesis,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
March 1996, Biochemical and biophysical research communications,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
January 2002, Mutation research,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
June 2003, Mutation research,
E Madrigal-Bujaidar, and M Cassani, and S Martínez, and T Morales
December 1984, Mutation research,
Copied contents to your clipboard!